ADARx Pharmaceuticals, Inc. Common Stock (ADRX) — Capital Reinvestment Ratio
ADARx Pharmaceuticals, Inc. Common Stock (ADRX) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow ($313.44 Million) in capital expenditures ($992.00K). See ADARx Pharmaceuticals, Inc. Common Stock free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ADARx Pharmaceuticals, Inc. Common Stock Capital Reinvestment Ratio (2025–2025)
This chart tracks ADARx Pharmaceuticals, Inc. Common Stock's Capital Reinvestment Ratio across 1 annual periods. See ADARx Pharmaceuticals, Inc. Common Stock (ADRX) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Capital Reinvestment Ratio for ADARx Pharmaceuticals, Inc. Common Stock (2025–2025)
Year-by-year Capital Reinvestment Ratio for ADARx Pharmaceuticals, Inc. Common Stock from 2025 to 2025. For the full cash flow conversion analysis, see cash flow conversion of ADARx Pharmaceuticals, Inc. Common Stock.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | $262.29 Million | $2.94 Million | — |